<DOC>
	<DOCNO>NCT01529957</DOCNO>
	<brief_summary>The purpose study evaluate safety tolerability nemonoxacin healthy Chinese volunteer .</brief_summary>
	<brief_title>A Study Nemonoxacin Malate Sodium Chloride Injection Administered Intravenous Infusion</brief_title>
	<detailed_description>Single dose safety tolerability study : evaluate safety tolerability intravenous infusion nemonoxacin 25mg , 50mg , 125mg , 250mg , 500mg , 750mg , 1000mg 1250mg . Single dose pharmacokinetic ( PK ) study : evaluate PK profile dose 250mg , 500mg 750mg intravenous infusion nemonoxacin . Multiple dose study : evaluate PK profile dose 500mg , 650mg 750mg intravenous infusion nemonoxacin consecutive 10 day .</detailed_description>
	<criteria>1 . Healthy male female , age 18 ~45 2 . A male volunteer willing use doublebarrier contraception study complete , make partner pregnant study within 3 month complete study 3 . Volunteers never use tobacco nicotinecontaining product within three month use investigational product 4 . Volunteers willing abstain caffeine xanthine contain drink food within 24h enrol study throughout study , coffee tea , chocolate , alcohol , grapefruit juice , orange juice , etc . 5 . The body mass index ( BMI ) volunteer must 19~24 , weight male least 50kg , female least 45kg . 6 . Volunteers able sign inform consent form ( ICF ) accord . 1 . History diabetes , cardiovascular , hepatic renal disease . 2 . Had surgery trauma within 6 month prior study 3 . Alcohol drug abuse 4 . HIV , HBV HCV positive 5. subject use know hepatic enzyme inducer/hepatic enzyme inhibitor product within 30 day prior study 6 . Used prescribed drug ( include traditional chinese medicine ) within 14 day prior study 7 . Donated 400ml blood plasma within 3 month prior study 8 . Have abnormal laboratory examination value exceed normal range 10 % 9 . Drug allergies 10 . Have cardiac disorder family history cardiac disorder 11 . Have abnormal 12lead ECG screen 12 . Pregnant lactate 13 . Participated study within 3 month prior study 14. accord investigator 's judgment , affect safety efficacy evaluation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>Volunteers</keyword>
</DOC>